1492 Capital Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FAM
KFO
1492 Capital Management's NEO Position: Q1 2021 in Review
1492 Capital Management sold out of NeoGenomics (NEO) in Q1 2021, closing a stake of 90,465 shares — an estimated $4.87M sold.
1492 Capital Management first reported a position in NEO in Q3 2014 and held it in 26 quarters. The position peaked at $5.93M in Q4 2015. 332 funds tracked by Wall St. Rank hold NEO as of Q1 2021.
- 1492 Capital Management reported no remaining NeoGenomics position as of Q1 2021 after selling out during the quarter.
- 1492 Capital Management sold 90,465 NeoGenomics shares in Q1 2021, an estimated $4.87M.
- 1492 Capital Management first reported a position in NeoGenomics in Q3 2014 and held it in 26 quarters.
- 1492 Capital Management's NeoGenomics position peaked at $5.93M in Q4 2015.
- 332 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2021.
Based on 1492 Capital Management's 13F filing for Q1 2021, filed 12 May 2021.